FXYD3 and cancer: Differential gene expression and gene ranking analyses revealed that the expression of CD74, HLA-DRA, HLA-DRB1, and FXYD3 was elevated in MHC-II+ cancer cells, whereas the expression of LOXL2 and DLL4 was increased in MHC-II− cancer cells (Figure S6D).